Raras
Buscar doenças, sintomas, genes...
Rabdomiossarcoma, alveolar
ORPHA:99756CID-10 · C49.9CID-11 · 2B55.1OMIM 268220DOENÇA RARA

É um tipo de câncer que cresce rapidamente e se forma em tecidos como músculos, gordura ou ossos. Ele é caracterizado pela presença de células arredondadas com características de células musculares e por um tecido de suporte com vasos sanguíneos e fibras, que lembra um padrão de pequenos "sacos" ou "bolhas". Geralmente, esse tumor surge nos braços e nas pernas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É um tipo de câncer que cresce rapidamente e se forma em tecidos como músculos, gordura ou ossos. Ele é caracterizado pela presença de células arredondadas com características de células musculares e por um tecido de suporte com vasos sanguíneos e fibras, que lembra um padrão de pequenos "sacos" ou "bolhas". Geralmente, esse tumor surge nos braços e nas pernas.

Pesquisas ativas
6 ensaios
23 total registrados no ClinicalTrials.gov
Publicações científicas
1.236 artigos
Último publicado: 2026 Apr 16

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.018
Austria
Herança
Multigenic/multifactorial
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C49.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

Rabdomiossarcoma alveolar
HP:0001442
2sintomas
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 2 características clínicas mais associadas, ordenadas por frequência.

Rabdomiossarcoma alveolarAlveolar rhabdomyosarcoma
HP:0001442

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.236PubMed
Últimos 10 anos200publicações
Pico202255 papers
Linha do tempo
2026Hoje · 2026🧪 1991Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial.

PAX3Paired box protein Pax-3Part of a fusion gene inAltamente restrito
FUNÇÃO

Transcription factor that may regulate cell proliferation, migration and apoptosis. Involved in neural development and myogenesis. Transcriptional activator of MITF, acting synergistically with SOX10 (PubMed:21965087)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Specification of the neural plate borderTranscriptional and post-translational regulation of MITF-M expression and activity
MECANISMO DE DOENÇA

Waardenburg syndrome 1

WS1 is an autosomal dominant disorder characterized by non-progressive sensorineural deafness, pigmentary disturbances such as frontal white blaze of hair, heterochromia of irides, white eyelashes, leukoderma, and wide bridge of nose owing to lateral displacement of the inner canthus of each eye (dystopia canthorum). WS1 shows variable clinical expression and some affected individuals do not manifest hearing impairment or iris pigmentation disturbances. Dystopia canthorum is the most consistent sign and is found in 98% of the patients.

EXPRESSÃO TECIDUAL(Baixa expressão)
Glândula salivar
4.6 TPM
Cerebelo
4.0 TPM
Cérebro - Hemisfério cerebelar
2.3 TPM
Skin Not Sun Exposed Suprapubic
2.3 TPM
Testículo
2.1 TPM
OUTRAS DOENÇAS (4)
Waardenburg syndrome type 1alveolar rhabdomyosarcomaWaardenburg syndrome type 3craniofacial-deafness-hand syndrome
HGNC:8617UniProt:P23760
NF1NeurofibrominDisease-causing somatic mutation(s) inAltamente restrito
FUNÇÃO

Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity

LOCALIZAÇÃO

NucleusNucleus, nucleolusCell membrane

VIAS BIOLÓGICAS (1)
RAS signaling downstream of NF1 loss-of-function variants
MECANISMO DE DOENÇA

Neurofibromatosis 1

A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
17.9 TPM
Cérebro - Hemisfério cerebelar
17.1 TPM
Cerebelo
15.3 TPM
Nervo tibial
14.9 TPM
Tireoide
14.1 TPM
OUTRAS DOENÇAS (12)
neurofibromatosis, familial spinalneurofibromatosis type 1juvenile myelomonocytic leukemiaWatson syndrome
HGNC:7765UniProt:P21359
TP53Cellular tumor antigen p53Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apop

LOCALIZAÇÃO

CytoplasmNucleusNucleus, PML bodyEndoplasmic reticulumMitochondrion matrixCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (10)
TP53 Regulates Metabolic GenesRegulation of TP53 ExpressionRegulation of TP53 DegradationOncogene Induced SenescenceOxidative Stress Induced Senescence
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
73.0 TPM
Skin Sun Exposed Lower leg
37.0 TPM
Skin Not Sun Exposed Suprapubic
35.2 TPM
Fibroblastos
32.9 TPM
Ovário
32.4 TPM
OUTRAS DOENÇAS (29)
Li-Fraumeni syndromenasopharyngeal carcinoma, susceptibility to, 1hepatocellular carcinomafamilial pancreatic carcinoma
HGNC:11998UniProt:P04637
FOXO1Forkhead box protein O1Part of a fusion gene inAltamente restrito
FUNÇÃO

Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress (PubMed:10358076, PubMed:12228231, PubMed:15220471, PubMed:15890677, PubMed:18356527, PubMed:19221179, PubMed:20543840, PubMed:21245099). Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3' (PubMed:10358076). Activity suppressed by insu

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genesRegulation of gene expression in beta cellsFOXO-mediated transcription of cell death genesFOXO-mediated transcription of cell cycle genesRegulation of localization of FOXO transcription factors
MECANISMO DE DOENÇA

Rhabdomyosarcoma 2

A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
110.7 TPM
Nervo tibial
109.3 TPM
Útero
73.4 TPM
Músculo esquelético
66.8 TPM
Fallopian Tube
65.4 TPM
OUTRAS DOENÇAS (1)
alveolar rhabdomyosarcoma
HGNC:3819UniProt:Q12778
PAX7Paired box protein Pax-7Part of a fusion gene inAltamente restrito
FUNÇÃO

Transcription factor that is involved in the regulation of muscle stem cells proliferation, playing a role in myogenesis and muscle regeneration

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Specification of the neural plate border
MECANISMO DE DOENÇA

Rhabdomyosarcoma 2

A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
1.7 TPM
Músculo esquelético
1.5 TPM
Córtex cerebral
1.3 TPM
Brain Anterior cingulate cortex BA24
0.5 TPM
Brain Spinal cord cervical c-1
0.4 TPM
OUTRAS DOENÇAS (2)
alveolar rhabdomyosarcomamyopathy, congenital, progressive, with scoliosis
HGNC:8621UniProt:P23759

Variantes genéticas (ClinVar)

1,794 variantes patogênicas registradas no ClinVar.

🧬 PAX7: NM_001135254.2(PAX7):c.322-4G>C ()
🧬 PAX7: NM_001135254.2(PAX7):c.742G>T (p.Glu248Ter) ()
🧬 PAX7: GRCh37/hg19 1p36.32-36.12(chr1:4436802-22782007)x2 ()
🧬 PAX7: GRCh37/hg19 1p36.21-36.12(chr1:16194137-20561434)x1 ()
🧬 PAX7: GRCh37/hg19 1p36.13-36.12(chr1:17291707-23016395)x4 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 19 variantes classificadas pelo ClinVar.

13
6
Patogênica (68.4%)
VUS (31.6%)
VARIANTES MAIS SIGNIFICATIVAS
PAX3: NM_181458.4(PAX3):c.178G>T (p.Val60Leu) [Likely pathogenic]
PAX3: NM_181458.4(PAX3):c.452-1G>A [Pathogenic/Likely pathogenic]
PAX7: NM_001135254.2(PAX7):c.220C>T (p.Arg74Ter) [Pathogenic/Likely pathogenic]
PAX3: NM_181458.4(PAX3):c.540C>G (p.Ser180Arg) [Conflicting classifications of pathogenicity]
PAX3: NM_181458.4(PAX3):c.580G>A (p.Glu194Lys) [Conflicting classifications of pathogenicity]

Vias biológicas (Reactome)

45 vias biológicas associadas aos genes desta condição.

HATs acetylate histones Specification of the neural plate border Transcriptional and post-translational regulation of MITF-M expression and activity Regulation of RAS by GAPs RAS signaling downstream of NF1 loss-of-function variants Activation of NOXA and translocation to mitochondria Activation of PUMA and translocation to mitochondria Pre-NOTCH Transcription and Translation Oxidative Stress Induced Senescence Formation of Senescence-Associated Heterochromatin Foci (SAHF) Oncogene Induced Senescence DNA Damage/Telomere Stress Induced Senescence SUMOylation of transcription factors Autodegradation of the E3 ubiquitin ligase COP1 Association of TriC/CCT with target proteins during biosynthesis Pyroptosis TP53 Regulates Metabolic Genes Ub-specific processing proteases Ovarian tumor domain proteases Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Interleukin-4 and Interleukin-13 signaling TP53 Regulates Transcription of DNA Repair Genes TP53 Regulates Transcription of Genes Involved in Cytochrome C Release TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain TP53 Regulates Transcription of Caspase Activators and Caspases TP53 Regulates Transcription of Death Receptors and Ligands TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest Regulation of TP53 Expression Regulation of TP53 Activity through Phosphorylation Regulation of TP53 Degradation Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Association with Co-factors Regulation of TP53 Activity through Methylation AKT phosphorylates targets in the nucleus Regulation of gene expression in beta cells AKT-mediated inactivation of FOXO1A Constitutive Signaling by AKT1 E17K in Cancer MAPK6/MAPK4 signaling Regulation of localization of FOXO transcription factors FOXO-mediated transcription of cell death genes FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes Regulation of FOXO transcriptional activity by acetylation FOXO-mediated transcription of cell cycle genes

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 35
2Fase 26
1Fase 11
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 15 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Rabdomiossarcoma, alveolar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

23 ensaios clínicos encontrados, 6 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
490 papers (10 anos)
#1

Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer.

International journal of molecular sciences2026 Mar 06

Studies of the pediatric soft tissue cancer alveolar rhabdomyosarcoma have contributed to the current understanding of the diverse set of molecular changes that occur as part of the gene amplification process. In accord with the traditional view of amplification, the amplicon from the 2p24 chromosomal region primarily involves a single protein-coding gene (MYCN). In contrast, amplification of the 12q13-q14 chromosomal region involves a gene-rich region in which there are at least two critical protein-coding oncogenic targets (CDK4 and SHMT2). Amplicons involving the 1p36 and 13q14 chromosomal regions co-occur as part of a multistep process in which a mutation, in this case a translocation that forms a gene fusion (PAX7::FOXO1), is followed by amplification. Analysis of the amplicon involving the 13q31 region highlights an example of a situation in which the critical amplification target is a gene for a non-coding RNA (MIR17HG) instead of a protein-coding gene. Translational studies of the prognostic significance of these amplicons emphasize important considerations encountered in defining useful prognostic markers. Finally, preclinical investigations revealed that some amplification events (CDK4 and SHMT2) decrease susceptibility to drugs that directly target the amplified gene products and increase susceptibility to drugs targeting proteins that function in signaling pathways downstream of these amplified gene products. These combined studies in alveolar rhabdomyosarcoma emphasize the biological and clinical complexities of gene amplification in cancer.

#2

Beyond the Globe: Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms.

Translational vision science &amp; technology2026 Mar 02

Recent advances in molecular pathology have transformed the diagnostic landscape and management of human cancer. Increasingly, integration of genomic and epigenomic data with conventional histopathology has improved tumor classification, refined prognostic assessment, and revealed previously unsuspected therapeutic targets. High-throughput techniques such as next-generation sequencing, gene fusion panels, and methylation arrays have expanded applicability to formalin-fixed tissue and enabled simultaneous evaluation of multiple cancer-defining alterations/genetic drivers. In optic nerve gliomas, MAPK pathway activation through BRAF or FGFR1 alterations, or NF1 inactivation, is a basic biological feature with diagnostic implications, while MEK inhibitors may be of clinical benefit in selected patients. Optic nerve sheath/orbital meningiomas demonstrate divergent molecular landscapes depending on location, with NF2-driven and non-NF2-driven pathways informing recurrence risk and behavior. In the orbit, characteristic genetic drivers facilitate diagnosis of mesenchymal tumors such as solitary fibrous tumor (NAB2::STAT6) and alveolar rhabdomyosarcoma (PAX3/7::FOXO1), while molecular profiling assists in distinguishing challenging peripheral nerve and melanocytic lesions. Similarly, lacrimal gland neoplasms parallel salivary gland counterparts, with recurrent fusions such as PLAG1, HMGA2, and MYB::NFIB of great diagnostic utility. These advances underscore the growing role of molecular diagnostics in improving accuracy, guiding prognostication, and refining the classification of rare ocular tumors. As high-throughput techniques continue to mature, integration with evolving spatial and single-cell-based approaches promises to expand our understanding and further personalize diagnostic and therapeutic strategies.

#3

Perianal Rhabdomyosarcoma Mimicking Perianal Abscess: Case Report and Literature Review.

Case reports in oncology2026

Perianal rhabdomyosarcoma is an exceedingly rare and aggressive soft tissue malignancy that can mimic benign conditions, such as perianal abscesses, which complicates its diagnosis and treatment. This study reports a case of perianal RMS and discusses the management approach and the challenges in diagnosis. A 26-year-old woman with a past medical history of breast cancer, treated with partial mastectomy, chemotherapy, and radiation therapy, presented with a recurrent perianal mass initially drained multiple times for presumed abscesses. Upon further evaluation, physical examination revealed a 7-cm perianal wound with purulent and bloody discharge. Imaging studies revealed a lobulated mass in the perineal area with involvement of the anus. Biopsy confirmed the diagnosis of alveolar RMS. The patient was treated with six cycles of neoadjuvant chemotherapy, followed by excisional biopsy. The tumor was resected with clear margins and immunohistochemical analysis confirmed the diagnosis. Adjuvant chemotherapy was initiated, and the patient remains asymptomatic at 6-month follow-up. Rhabdomyosarcoma should be considered in the differential diagnosis of perianal masses, especially in cases with recurrence or unusual clinical presentation. Early recognition and appropriate multidisciplinary management, including chemotherapy and surgical excision, are essential for favorable outcomes.

#4

Clinicopathological and molecular features of breast metastases in alveolar rhabdomyosarcoma: A series of 3 cases.

Annals of diagnostic pathology2026 Mar 03

Breast metastases are exceedingly uncommon in pediatric and adolescent populations; however, rhabdomyosarcoma (RMS) is the predominant histological subtype in such cases. Metastatic RMS and primary breast tumors may exhibit overlapping histological features, potentially leading to misclassification. In a cohort of 318 RMS patients treated at our institution between 2011 and 2025, we identified three female patients aged 16, 17, and 31 years who showed breast metastases. All three patients had alveolar RMS (ARMS), with their primary tumors located in the sinonasal region (two patients) and buttocks (one patient). The detection of breast metastases occurred within 0-9 months of the initial diagnosis. Histopathological examination revealed tumors composed of small, round cells organized in alveolar or solid nests, demonstrating infiltrative growth and significant cytologic atypia. Immunohistochemical analyses showed the tumor cells to display strong diffuse positivity for desmin, MyoD1, and myogenin, with Ki-67 proliferation indices that ranged from 70% to 85%. All tumors exhibited FOXO1 rearrangements, as determined by fluorescence in situ hybridization, with two tumors demonstrating 3' signal amplification. The tumor for patient 3 displayed a PAX3::FOXO1 fusion by next generation sequencing. After 12-months follow-up, patient 3 remained alive with disease, whereas patients 1 and 2 were lost to follow-up. In summary, breast masses in adolescent and middle-aged women comprised of small round cell tumor cells with an invasive growth pattern should prompt consideration of metastatic ARMS as a diagnostic possibility. Accurate diagnosis requires a careful integration of medical history, morphologic and immunophenotypic tumoral features, and confirmation through the detection of specific alterations in the FOXO1 gene.

#5

Orbital rhabdomyosarcoma in an adult: a misleading presentation.

Radiology case reports2026 May

Rhabdomyosarcoma is the most common malignant mesenchymal tumor in children, whereas its occurrence in adults is exceptionally rare. When it occurs in this population, initial presentation with nonspecific rhinologic symptoms is unusual and may delay recognition of the underlying malignancy. We report the case of a 29-year-old woman who presented with progressive right-sided nasal obstruction and hyposmia, subsequently complicated by the rapid onset of unilateral proptosis. Cross-sectional imaging revealed a poorly circumscribed ethmoido-orbito-nasal mass with skull base erosion and orbital invasion, exhibiting aggressive radiologic features that initially raised suspicion for esthesioneuroblastoma. Histopathological examination ultimately confirmed alveolar rhabdomyosarcoma, staged as T2BN1M0 (IRS Group III). The patient underwent multimodal treatment combining VAC chemotherapy and conformal radiotherapy (45 Gy), resulting in an excellent clinical and radiologic response, with complete resolution of proptosis and significant visual recovery at 1-year follow-up. This case emphasizes the diagnostic challenges of adult orbital rhabdomyosarcoma with sinonasal extension and highlights the pivotal role of advanced imaging and histopathology in guiding accurate diagnosis and appropriate management. The rarity and unusual clinical presentation of this case underscore its value for publication.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC662 artigos no totalmostrando 199

2026

Perianal Rhabdomyosarcoma Mimicking Perianal Abscess: Case Report and Literature Review.

Case reports in oncology
2026

Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer.

International journal of molecular sciences
2026

Clinicopathological and molecular features of breast metastases in alveolar rhabdomyosarcoma: A series of 3 cases.

Annals of diagnostic pathology
2026

Orbital rhabdomyosarcoma in an adult: a misleading presentation.

Radiology case reports
2026

Beyond the Globe: Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms.

Translational vision science &amp; technology
2026

Diagnostic value of ultrasound parameters combined with clinical features in children with alveolar and non- alveolar rhabdomyosarcoma.

Medical ultrasonography
2026

Pelvic Location Predicts Worse Outcomes in Alveolar Rhabdomyosarcoma: Underuse of Radiotherapy and Missed Survival Benefit.

Journal of surgical oncology
2026

Intratumor heterogeneity and clonal evolution in sarcomas: Molecular, cellular, and functional drivers of therapy resistance.

Seminars in cancer biology
2026

Alveolar rhabdomyosarcoma with multiple bone marrow metastases: a case report.

BJR case reports
2026

Predictors of survival in alveolar rhabdomyosarcoma in the US.

Annals of medicine and surgery (2012)
2025

MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN and is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma.

bioRxiv : the preprint server for biology
2025

Alveolar rhabdomyosarcoma of the paranasal sinuses with delayed diagnosis in a resource-constrained clinical setting: a case report.

Oxford medical case reports
2025

Primary Uterine Alveolar Rhabdomyosarcoma: A Rare Entity.

International journal of surgical pathology
2025

Primary Gastric Alveolar Rhabdomyosarcoma.

Internal medicine (Tokyo, Japan)
2025

Generation of an iPSC-derived alveolar rhabdomyosarcoma cell line during directed endothelial differentiation.

Stem cell research
2025

A case report: pediatric rhabdomyosarcoma presenting with bone marrow metastasis.

BMC pediatrics
2025

Cutaneous metastases of alveolar rhabdomyosarcoma in a young adult.

JAAD case reports
2025

Pineal alveolar rhabdomyosarcoma with PAX3 fusion: A specific clinico-radio-histomolecular type in the CNS.

Journal of neuropathology and experimental neurology
2025

PLA2 driven lipid signaling drives ARMS tumorigenic cell properties.

Cell communication and signaling : CCS
2025

Case Report: Relapsed alveolar rhabdomyosarcoma treated with abemaciclib, temozolomide, and irinotecan in the JPCS study.

Frontiers in oncology
2025

Fusion-Negative Rhabdomyosarcoma: Clinical Application of Targeted RNA Sequencing.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2025

Alveolar Rhabdomyosarcoma With Bone Marrow Metastases and Disseminated Intravascular Coagulation Mimicking Acute Lymphoblastic Leukemia: A Case Report.

Cureus
2025

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

bioRxiv : the preprint server for biology
2025

Case Report of Maxillary Alveolar Rhabdomyosarcoma Misdiagnosed as Periapical Lesion: Clinicopathological Alerts and Life-Saving Lessons for Dentists.

Australian endodontic journal : the journal of the Australian Society of Endodontology Inc
2025

Alveolar rhabdomyosarcoma of cervix: A case report.

Medicine
2025

Alveolar paratesticular rhabdomyosarcoma mimicking an epididymal abscess: An intraoperative discovery.

Urology case reports
2025

The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumours.

Pathology oncology research : POR
2025

Small cell carcinoma with rhabdomyosarcomatous differentiation of the urinary bladder: an integrated clinicopathological and molecular characterization of five cases.

Virchows Archiv : an international journal of pathology
2025

Proton beam therapy for a patient with prostatic rhabdomyosarcoma: a case report and review of the literature.

Frontiers in oncology
2025

Synthetic inhibition of the SUMO pathway by targeting the SAE1 component via TAK-981 compound impairs growth and chemosensitizes embryonal and alveolar rhabdomyosarcoma cell lines.

Molecular and cellular biochemistry
2025

Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls.

International journal of molecular sciences
2025

[Detection of MYOD1-mutation of rhabdomyosarcoma and its clinicopathological characteristics].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2025

18 F-FAPI PET/CT in An Adult Orbital-Nasal Alveolar Rhabdomyosarcoma: Comparisons With 18 F-FDG PET/CT.

Clinical nuclear medicine
2025

Age-linked DNA methylation and gene expression patterns in parameningeal head and neck alveolar rhabdomyosarcoma reveal CDK9 as a promising therapeutic target.

Pharmacological research
2025

Rhabdomyosarcoma in adults with severe thrombocytopenia: Challenges in clinical management and therapeutic complications.

Respiratory medicine case reports
2025

Hyperbaric Oxygen Therapy in Doxorubicin Extravasation: A Promising Future Treatment?: A Case Report.

Journal of pediatric hematology/oncology
2025

PAX translocations remodel mitochondrial metabolism through altered leucine usage in rhabdomyosarcoma.

Cell
2025

The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma.

Biomolecules
2025

Primary pineal alveolar rhabdomyosarcoma in an adult patient: a case report and literature review.

BMC neurology
2025

Rhabdomyosarcoma Harboring NRAS or HRAS Mutation Arising in Giant Congenital Melanocytic Nevus: Report of 2 Cases.

The American Journal of dermatopathology
2025

Alveolar Rhabdomyosarcoma of Nasopharynx and Paranasal Sinuses in Children Diagnosis and Treatment-Review of the Literature and Case Report.

Medicina (Kaunas, Lithuania)
2025

Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the Cooperative Weichteilsarkom Studiengruppe CWS.

Cancer medicine
2025

[Alveolar rhabdomyosarcoma with amplification of 12q15 region including MDM2 and FRS2 genes: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2024

Primary perianal alveolar rhabdomyosarcoma with uncommon metastatic sites: a case report and follow-up using 18F-FDG PET/CT.

Frontiers in medicine
2024

Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.

EClinicalMedicine
2024

[Characteristics of the cytogenetic variants of alveolar rhabdomyosarcoma].

Arkhiv patologii
2025

Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion-Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS-2002P and RMS 2005 Studies and the Soft Tissue Sarcoma Registry.

Pediatric blood &amp; cancer
2024

Alveolar Paratesticular Rhabdomyosarcoma in an Adult Patient With PAX3-FOXO1 Fusion and Unfavorable Evolution.

Cureus
2024

Isolated Pancreatic Metastasis in a Patient With Orbital Rhabdomyosarcoma: A Report of a Rare Case.

Cureus
2024

Propofol-induced transient arginine vasopressin deficiency.

Endocrinology, diabetes &amp; metabolism case reports
2024

A Case Report on Alveolar Rhabdomyosarcoma in an Indigenous Dog.

Veterinary medicine and science
2024

Primary Gastric Alveolar Rhabdomyosarcoma: A Potent Mimicker of Neuroendocrine Carcinoma.

Cureus
2024

Caspase-Activated DNase localizes to cancer causing translocation breakpoints during cell differentiation.

bioRxiv : the preprint server for biology
2024

A comparative in vivo study of hyperthermic intraperitoneal chemotherapy with cisplatin versus doxorubicin versus cisplatin plus doxorubicin for the treatment of intra-abdominally disseminated alveolar rhabdomyosarcoma in mice.

Pediatric blood &amp; cancer
2025

Head and neck sarcomas: Thirty years of experience in a tertiary referral center in Brazil.

Head &amp; neck
2024

A bright future for multidisciplinary approach to cancer care in the setting of limited resource.

Translational oncology
2024

A rare case of perianal alveolar rhabdomyosarcoma.

Clinical case reports
2024

Evaluation of Hi-C Sequencing for Detection of Gene Fusions in Hematologic and Solid Tumor Pediatric Cancer Samples.

Cancers
2024

PAX fusion proteins deregulate gene networks controlling mitochondrial translation in pediatric rhabdomyosarcoma.

bioRxiv : the preprint server for biology
2025

Sinonasal alveolar rhabdomyosarcoma with PAX3::NCOA1 fusion expressing SOX10 and with nodal metastases: a double diagnostic pitfall.

Journal of clinical pathology
2024

Entinostat as a combinatorial therapeutic for rhabdomyosarcoma.

Scientific reports
2024

Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" Cases.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2024

Massive Bone Marrow Infiltration by Disseminated Alveolar Rhabdomyosarcoma Mimicking Acute Leukemia.

Journal of pediatric hematology/oncology
2024

Primary Alveolar Rhabdomyosarcoma of the Thyroid: A Case Report.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2024

Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.

Rare tumors
2024

Hyperfibrinolysis during the treatment of rhabdomyosarcoma.

Research and practice in thrombosis and haemostasis
2024

ISLET-1 expression in soft tissue neoplasms reveals high sensitivity but moderate specificity for desmoplastic small round cell tumors and potential utility as a diagnostic biomarker.

Pathology, research and practice
2024

A Case of Alveolar Rhabdomyosarcoma of the Nasal Cavity in an Adult: An Unusual Location.

Cureus
2024

An extremely rare case of primary alveolar rhabdomyosarcoma in the central nervous system.

Surgical neurology international
2024

Pathologic features of head and neck adult rhabdomyosarcoma: Case series.

International journal of surgery case reports
2024

18F-FDG PET/CT findings of paratesticular alveolar rhabdomyosarcoma.

Cancer innovation
2024

Developmental and therapeutic implications of IL4ra expression for rhabdomyosarcoma.

Transgenic research
2024

Case report: Lymph node metastasis of pelvic alveolar rhabdomyosarcoma diagnosed by fine needle aspiration cytology.

Frontiers in oncology
2024

Case report: A left forearm mass with eccentric intramedullary ulnar destruction diagnosed as alveolar rhabdomyosarcoma and treated by wide resection and free vascularized fibular graft.

Frontiers in oncology
2024

Spontaneous tumor lysis syndrome in an adult with alveolar rhabdomyosarcoma: a challenging diagnosis.

Oxford medical case reports
2024

Evaluation of Hi-C sequencing for the detection of gene fusions in hematologic and solid pediatric cancer samples.

medRxiv : the preprint server for health sciences
2024

Embryonal and alveolar rhabdomyosarcoma in adolescents/young adults, adults and older adults: a population-based cohort study.

Japanese journal of clinical oncology
2024

Pediatric Prostatic Alveolar Rhabdomyosarcoma Presenting with Metastatic Spinal Cord Compression in the Thoracic Spine: A Case Report and Review of the Literature.

Cureus
2024

Severe Vincristine-Induced Peripheral Neuropathic Weakness in Both Lower Limbs in an Asian Adolescent with CYP3A4 rs2740574 TT Genotype.

Pharmacogenomics and personalized medicine
2025

Multimodality Imaging Evaluation of Nasal Rhabdomyosarcoma in Adults: A Case Report and Literature Review.

Current radiopharmaceuticals
2024

FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.

Genes, chromosomes &amp; cancer
2024

Primary alveolar rhabdomyosarcoma of the brain: a case report.

Journal of medical case reports
2024

Unraveling the Clinicopathological Diversity and Subtypes of Rhabdomyosarcoma: A Study From a Tertiary Care Center.

Cureus
2024

Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response.

International journal of molecular sciences
2024

Alveolar Rhabdomyosarcoma of the Temporal Region with Metastatic Cervical Lymph Node.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2023

Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers.

Frontiers in immunology
2024

Neopetrotaurines A-C, Isoquinoline Alkaloids with an Unprecedented Taurine Bridge from the Sponge Neopetrosia sp.

Journal of natural products
2024

[Cytopathological characterization of alveolar rhabdomyosarcoma in serous effusions].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2024

Incidence and survival for childhood cancer by endorsed non-stage prognostic indicators in Australia.

Pediatric blood &amp; cancer
2023

Silent Killer in the Nose: Two Cases of Nasal Alveolar Rhabdomyosarcoma in Adults.

Cureus
2023

Orbital Rhabdomyosarcoma Masquerading as a Dermoid Cyst: A Case Report and Review of the Literature.

Cureus
2024

BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma.

EMBO reports
2024

Prognostic Factors in Pediatric Alveolar Rhabdomyosarcoma: SEER Analysis of 277 Cases.

Clinical pediatrics
2023

PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution.

Nature communications
2023

Induction Chemotherapy Prior to Endoscopic Resection of Alveolar Rhabdomyosarcoma.

Cureus
2023

An unusual presentation of neonatal rhabdomyosarcoma: a case report.

Frontiers in pediatrics
2023

Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.

Cancers
2024

"My Home Away From Home": Community Support for International Pediatric and Young Adult Patients and Their Families in End-of-Life Care and Bereavement.

Journal of palliative medicine
2024

Transorbital endoscopic ultrasonography (with video).

Gastrointestinal endoscopy
2023

Simultaneous Occurrence of Multiple Neoplasms in Children with Cancer Predisposition Syndromes: Collaborating with Abnormal Genes.

Genes
2024

Functional Genomics of Novel Rhabdomyosarcoma Fusion-Oncogenes Using Zebrafish.

Methods in molecular biology (Clifton, N.J.)
2023

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.

Frontiers in immunology
2023

A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma.

Pediatric blood &amp; cancer
2023

Detection of various fusion genes by one-step RT-PCR and the association with clinicopathological features in 242 cases of soft tissue tumor.

Frontiers in cell and developmental biology
2023

CircAFF1 Is a Circular RNA with a Role in Alveolar Rhabdomyosarcoma Cell Migration.

Biomedicines
2023

PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.

Virchows Archiv : an international journal of pathology
2025

Alveolar Rhabdomyosarcoma of the Nasal Dorsum of a Pediatric Patient: A Case Report.

Ear, nose, &amp; throat journal
2024

Impact of age on survival according to molecular tumor findings in children and adolescents with soft-tissue and bone sarcoma: The BIOSCA project.

Cancer epidemiology
2023

A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features.

Scientific reports
2023

18 F-FDG PET/CT of Alveolar Rhabdomyosarcoma of Prostate in a 17-Year-Old Boy.

Clinical nuclear medicine
2023

Alveolar rhabdomyosarcoma with multiple bone marrow infiltration.

The Lancet. Oncology
2023

Clinical-pathologic profile of head and neck rhabdomyosarcoma in children: a systematic review.

Journal of the Korean Association of Oral and Maxillofacial Surgeons
2023

Primary alveolar rhabdomyosarcoma in the stomach of an adult: A case report.

Oncology letters
2023

Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.

Cancer medicine
2023

Intraspinal alveolar rhabdomyosarcoma: A case report.

Asian journal of surgery
2023

Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.

BMC cancer
2023

Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group.

Cancer
2023

Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.

Cell death &amp; disease
2023

11C-Methionine PET/CT and 18F-FDG PET/CT in the Evaluation of Adult Alveolar Rhabdomyosarcoma.

Molecular imaging and radionuclide therapy
2023

Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors.

NPJ precision oncology
2023

[Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation].

Arkhiv patologii
2023

Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.

Science advances
2023

Breast Metastases After Treatment of Alveolar Rhabdomyosarcoma.

Journal of breast imaging
2023

Cutaneous Metastasis of Alveolar Rhabdomyosarcoma in a Child.

The American Journal of dermatopathology
2023

PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.

Pediatric blood &amp; cancer
2023

Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon.

Virchows Archiv : an international journal of pathology
2022

Baseline Characteristics, Prognostic Factors, and Treatment Outcomes for Adult Patients With Rhabdomyosarcoma (RMS).

Cureus
2022

Alveolar Rhabdomyosarcoma with CD 56 Positivity: A Mimic of Extranodal NK/T Cell Lymphoma.

Journal of cytology
2023

Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma.

The Journal of pathology
2023

FOXO1 and PAX5 Rearrangement in Alveolar Rhabdomyosarcoma in Saudi Pediatric Patients.

Fetal and pediatric pathology
2022

A case of complete response to chemotherapy followed by cystectomy for adult-onset rhabdomyosarcoma of the bladder.

Urology case reports
2022

Evidence for a chemical arms race between cuckoo wasps of the genus Hedychrum and their distantly related host apoid wasps.

BMC ecology and evolution
2022

Multimodality imaging evaluation of nasal sinus alveolar rhabdomyosarcoma: Two case reports.

Frontiers in medicine
2022

Alveolar rhabdomyosarcoma of epididymis: A case report.

Frontiers in oncology
2022

A rare case of clear cell sarcoma of the foot with a cascade of pathological misdiagnosis-the importance of expert sarcoma pathology.

Ecancermedicalscience
2022

Retroperitoneal alveolar rhabdomyosarcoma intruding into spinal canal: A case report and literature review.

Frontiers in medicine
2022

mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase.

International journal of molecular sciences
2022

Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma.

Molecular cancer
2022

Orbital Exenteration and Brachytherapy for the Treatment of Pediatric, Fusion-positive, Recurrent Rhabdomyosarcoma.

Plastic and reconstructive surgery. Global open
2023

A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.

Cancer medicine
2022

Adult omental alveolar rhabdomyosarcoma: An unusual site. A case report and literature review.

Annals of medicine and surgery (2012)
2024

A rare case of metastatic paraspinal rhabdomyosarcoma presenting with proptosis in an adult patient.

Orbit (Amsterdam, Netherlands)
2022

Haploinsufficiency of the lysosomal sialidase NEU1 results in a model of pleomorphic rhabdomyosarcoma in mice.

Communications biology
2022

CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy.

Oncoimmunology
2022

Alveolar rhabdomyosarcoma with massive bone marrow infiltration and disseminated intravascular coagulation mimicking acute leukemia.

EJHaem
2022

The RNA helicase DDX5 cooperates with EHMT2 to sustain alveolar rhabdomyosarcoma growth.

Cell reports
2022

Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity.

BMJ case reports
2022

Exploitation of High Tumour GSH Levels for Targeted siRNA Delivery in Rhabdomyosarcoma Cells.

Biomolecules
2022

Giant primary cardiac alveolar rhabdomyosarcoma of the right atrium.

Journal of cardiac surgery
2022

Exon skipping in genes encoding lineage-defining myogenic transcription factors in rhabdomyosarcoma.

Cold Spring Harbor molecular case studies
2022

Therapeutic targeting of ATR in alveolar rhabdomyosarcoma.

Nature communications
2022

Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma.

Science translational medicine
2022

A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research
2023

Spindle Cell/Sclerosing Rhabdomyosarcoma of the Orbit.

Ophthalmic plastic and reconstructive surgery
2022

Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness.

Oncoimmunology
2022

Tumor suppressive functions of WNT5A in rhabdomyosarcoma.

International journal of oncology
2022

Sarcoma of unknown primary: myth or reality?

Journal of the Egyptian National Cancer Institute
2022

Increasing the efficiency of hyperthermic intraperitoneal chemotherapy (HIPEC) by combination with a photosensitive drug in pediatric rhabdomyosarcoma in an animal model.

Pediatric blood &amp; cancer
2022

Alveolar rhabdomyosarcoma with cannibalism and erythroid leukaemia-like morphology.

International journal of laboratory hematology
2022

Alveolar Paratesticular Rhabdomyosarcoma in an Adult Patient Mimicking Epididymo-Orchitis: A Case Report and a Literature Review.

Cureus
2022

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.

Frontiers in oncology
2022

DVL1 and DVL3 require nuclear localisation to regulate proliferation in human myoblasts.

Scientific reports
2022

Plexin-B2 and Semaphorins Do Not Drive Rhabdomyosarcoma Proliferation or Migration.

Sarcoma
2022

Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

Rhabdomyosarcoma With Epithelioid Features And NSD3::FOXO1 Fusion: Evidence For Reconsideration Of Previously Reported FOXO1::FGFR1 Fusion.

International journal of surgical pathology
2022

Machine learning for rhabdomyosarcoma histopathology.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2022

Use of Porcine Urinary Bladder Matrix in Socket Reconstruction After Pediatric Orbital Exenteration.

Ophthalmic plastic and reconstructive surgery
2022

The Small Round Cell Sarcomas Complexities and Desmoplastic Presentation.

Acta cytologica
2022

Metastatic ethmoidal alveolar rhabdomyosarcoma presenting as a scalp nodule in an adult woman.

JAAD case reports
2022

Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction.

The American journal of pathology
2022

Alveolar Rhabdomyosarcoma of the Parotid Region: A Cytopathological Diagnosis.

Journal of cytology
2022

Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS).

Pediatric blood &amp; cancer
2022

Rhabdomyosarcoma With Diffuse Bone Marrow Metastases.

Cureus
2022

Adult Primary Pineal Alveolar Rhabdomyosarcoma with FOXO1 Gene Rearrangement and OLIG2 Expression: A Rare Case Report and Literature Review.

International journal of surgical pathology
2021

Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma-The French Experience.

Frontiers in pediatrics
2022

Primary Pulmonary Alveolar Rhabdomyosarcoma in a Pediatric Patient: A Case Report With Literature Review.

Cureus
2022

A rare cause of oligoanuric kidney failure - a diagnosis not to miss: Answers.

Pediatric nephrology (Berlin, Germany)
2022

[Expression and diagnostic value of NKX3.1 and NKX2.2 in mesenchymal chondrosarcoma].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2022

SMARCA4 biology in alveolar rhabdomyosarcoma.

Oncogene
2022

An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma.

Archives of pathology &amp; laboratory medicine
2021

[Primary Rhabdomyosarcoma of the Breast in a 16-Year-Old Girl].

Gan to kagaku ryoho. Cancer &amp; chemotherapy
2022

Primary Cutaneous Alveolar Rhabdomyosarcoma in an Elderly Adult: A Rare Potential Mimic of Merkel Cell Carcinoma.

The American Journal of dermatopathology
2022

[Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1].

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
2021

Metastatic Alveolar Rhabdomyosarcoma with Extensive Bone Marrow Replacement in an Older Adult.

Case reports in oncology
2022

EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma.

The Journal of pathology
2022

A new valid rhabdomyosarcoma spheroid culture model for in vitro evaluation of hypericin-based photodynamic therapy.

Pediatric blood &amp; cancer
2022

Primary cutaneous alveolar rhabdomyosarcoma: Report of a case and literature review.

International journal of dermatology
2021

Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis.

Frontiers in surgery
2021

A rhabdomyosarcoma hydrogel model to unveil cell-extracellular matrix interactions.

Biomaterials science
2021

Methylation profiling reveals novel molecular classes of rhabdomyosarcoma.

Scientific reports
2021

Encouraging Early Outcomes of Treatment With Arsenic Trioxide Combined With Chemotherapy for Alveolar Rhabdomyosarcoma in Children: 4 Case Reports.

Frontiers in oncology
2022

A high-risk alveolar rhabdomyosarcoma case with Duchenne muscular dystrophy.

Pediatrics international : official journal of the Japan Pediatric Society
2021

An Atypical Presentation of Sinonasal Tract Alveolar Rhabdomyosarcoma in a Young Male Patient Submitted to Multimodality Treatment.

Case reports in oncological medicine
2021

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.

Genes
2022

Primary Epithelioid Rhabdomyosarcoma of the Liver: Case Report of an Unusual Histological Variant.

International journal of surgical pathology
2022

Malignant Gonadal Germ Cell Tumors (Other Than Pure Germinoma) in Patients With Disorders of Sex Development: A Report of 21 Cases Based Largely on the Collection of Dr Robert E. Scully, Illustrating a High Frequency of Yolk Sac Tumor With Prominent Hepatoid and Glandular Features.

The American journal of surgical pathology
2021

Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma.

Scientific reports
2021

Primary alveolar rhabdomyosarcoma of bone.

Andes pediatrica : revista Chilena de pediatria
2021

Rare Adult Subtype of Rhabdomyosarcoma, a Common Childhood Soft Tissue Carcinoma.

Journal of investigative medicine high impact case reports
Ver todos os 662 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Rabdomiossarcoma, alveolar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Rabdomiossarcoma, alveolar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer.
    International journal of molecular sciences· 2026· PMID 41828638mais citado
  2. Beyond the Globe: Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms.
    Translational vision science &amp; technology· 2026· PMID 41769942mais citado
  3. Perianal Rhabdomyosarcoma Mimicking Perianal Abscess: Case Report and Literature Review.
    Case reports in oncology· 2026· PMID 41878616mais citado
  4. Clinicopathological and molecular features of breast metastases in alveolar rhabdomyosarcoma: A series of 3 cases.
    Annals of diagnostic pathology· 2026· PMID 41818880mais citado
  5. Orbital rhabdomyosarcoma in an adult: a misleading presentation.
    Radiology case reports· 2026· PMID 41798674mais citado
  6. Primary Prostatic Alveolar Rhabdomyosarcoma in Adult, a Diagnostic Pitfall: Report of an Extremely Rare Tumor.
    Int J Surg Pathol· 2026· PMID 41989357recente
  7. ALK-Negative Systemic Anaplastic Large Cell Lymphoma With Multifocal Cutaneous Involvement Responding to Brentuximab Vedotin.
    Am J Dermatopathol· 2026· PMID 41985092recente
  8. Resection of a Deep Pubic Alveolar Rhabdomyosarcoma With an Inferior Pubic Ramus Osteotomy Through a Perineal Approach: A Case Report.
    Case Rep Orthop· 2026· PMID 41970462recente
  9. Small Round Cell Tumors of Soft Tissue and Skeleton in Children and Youth: A Narrative and TruSight-Based Illustrative Review of Diagnostic Cases.
    Adv Anat Pathol· 2026· PMID 41930936recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:99756(Orphanet)
  2. OMIM OMIM:268220(OMIM)
  3. MONDO:0009994(MONDO)
  4. GARD:4701(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q4737958(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Rabdomiossarcoma, alveolar
Compêndio · Raras BR

Rabdomiossarcoma, alveolar

ORPHA:99756 · MONDO:0009994
Prevalência
<1 / 1 000 000
Herança
Multigenic/multifactorial
CID-10
C49.9 · Neoplasia maligna do tecido conjuntivo e tecidos moles, não especificados
CID-11
Ensaios
6 ativos
Prevalência
0.018 (Austria)
MedGen
UMLS
C0206655
Repurposing
2 candidatos
actinomycin-dRNA polymerase inhibitor
dactinomycin
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades